Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

Biol Psychiatry. 1996 Feb 1;39(3):213-5. doi: 10.1016/0006-3223(95)00585-4.

Authors

E Leiderman¹, I Zylberman, S R Zukin, T B Cooper, D C Javitt

Affiliation

¹ Department of Psychiatry, Albert Einstein College of Medicine/Bronx Psychiatric Center, Bronx, New York, USA.

PMID: 8837983
DOI: 10.1016/0006-3223(95)00585-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Adult
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / pharmacokinetics
Depression / blood
Depression / drug therapy*
Depression / psychology
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Glycine / administration & dosage*
Glycine / blood
Humans
Male
Middle Aged
Neurologic Examination / drug effects
Psychiatric Status Rating Scales*
Schizophrenia / blood
Schizophrenia / drug therapy*
Schizophrenic Psychology*
Treatment Outcome

Substances

Antipsychotic Agents
Glycine